vs

Side-by-side financial comparison of BIOLIFE SOLUTIONS INC (BLFS) and FIRST US BANCSHARES, INC. (FUSB). Click either name above to swap in a different company.

BIOLIFE SOLUTIONS INC is the larger business by last-quarter revenue ($18.8M vs $10.4M, roughly 1.8× FIRST US BANCSHARES, INC.). BIOLIFE SOLUTIONS INC runs the higher net margin — 58.9% vs 20.4%, a 38.5% gap on every dollar of revenue. On growth, BIOLIFE SOLUTIONS INC posted the faster year-over-year revenue change (24.3% vs 7.1%). Over the past eight quarters, FIRST US BANCSHARES, INC.'s revenue compounded faster (2.6% CAGR vs 1.0%).

Biolife Solutions Inc. develops, manufactures and distributes specialized biopreservation products and cold chain management solutions for the cell and gene therapy, biopharmaceutical and regenerative medicine industries. It offers cryopreservation media, automated thawing systems, and temperature monitoring tools, serving biotech firms, research institutions and clinical labs globally.

First Citizens Bancshares, Inc. is a bank holding company based in Raleigh, North Carolina and one of the largest banks in the United States. Its primary subsidiary is First Citizens Bank, which operates over 500 branches in 23 states. A second subsidiary is Silicon Valley Bank, which operates 39 offices in 15 states.

BLFS vs FUSB — Head-to-Head

Bigger by revenue
BLFS
BLFS
1.8× larger
BLFS
$18.8M
$10.4M
FUSB
Growing faster (revenue YoY)
BLFS
BLFS
+17.3% gap
BLFS
24.3%
7.1%
FUSB
Higher net margin
BLFS
BLFS
38.5% more per $
BLFS
58.9%
20.4%
FUSB
Faster 2-yr revenue CAGR
FUSB
FUSB
Annualised
FUSB
2.6%
1.0%
BLFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BLFS
BLFS
FUSB
FUSB
Revenue
$18.8M
$10.4M
Net Profit
$11.1M
$2.1M
Gross Margin
Operating Margin
7.2%
28.1%
Net Margin
58.9%
20.4%
Revenue YoY
24.3%
7.1%
Net Profit YoY
-11.1%
24.2%
EPS (diluted)
$0.23
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLFS
BLFS
FUSB
FUSB
Q4 25
$18.8M
$10.4M
Q3 25
$28.1M
$10.5M
Q2 25
$25.4M
$10.3M
Q1 25
$23.9M
$9.8M
Q4 24
$15.1M
$9.7M
Q3 24
$21.4M
$10.1M
Q2 24
$19.7M
$10.0M
Q1 24
$18.4M
$9.9M
Net Profit
BLFS
BLFS
FUSB
FUSB
Q4 25
$11.1M
$2.1M
Q3 25
$621.0K
$1.9M
Q2 25
$-15.8M
$155.0K
Q1 25
$-448.0K
$1.8M
Q4 24
$12.5M
$1.7M
Q3 24
$-1.7M
$2.2M
Q2 24
$-20.7M
$2.1M
Q1 24
$-10.2M
$2.1M
Operating Margin
BLFS
BLFS
FUSB
FUSB
Q4 25
7.2%
28.1%
Q3 25
-0.3%
23.9%
Q2 25
-65.5%
1.6%
Q1 25
-5.1%
23.8%
Q4 24
3.6%
23.8%
Q3 24
-2.0%
29.2%
Q2 24
-6.6%
27.4%
Q1 24
-17.9%
27.8%
Net Margin
BLFS
BLFS
FUSB
FUSB
Q4 25
58.9%
20.4%
Q3 25
2.2%
18.4%
Q2 25
-62.3%
1.5%
Q1 25
-1.9%
18.1%
Q4 24
82.5%
17.6%
Q3 24
-8.0%
22.0%
Q2 24
-105.1%
21.2%
Q1 24
-55.4%
21.3%
EPS (diluted)
BLFS
BLFS
FUSB
FUSB
Q4 25
$0.23
$0.36
Q3 25
$0.01
$0.32
Q2 25
$-0.33
$0.03
Q1 25
$-0.01
$0.29
Q4 24
$0.27
$0.29
Q3 24
$-0.04
$0.36
Q2 24
$-0.45
$0.34
Q1 24
$-0.22
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLFS
BLFS
FUSB
FUSB
Cash + ST InvestmentsLiquidity on hand
$33.0M
$73.5M
Total DebtLower is stronger
$5.0M
$10.9M
Stockholders' EquityBook value
$371.9M
$105.6M
Total Assets
$405.9M
$1.2B
Debt / EquityLower = less leverage
0.01×
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLFS
BLFS
FUSB
FUSB
Q4 25
$33.0M
$73.5M
Q3 25
$29.5M
$54.7M
Q2 25
$31.9M
$54.0M
Q1 25
$66.9M
$56.0M
Q4 24
$91.5M
$47.2M
Q3 24
$24.0M
$82.3M
Q2 24
$22.0M
$58.2M
Q1 24
$29.7M
$60.2M
Total Debt
BLFS
BLFS
FUSB
FUSB
Q4 25
$5.0M
$10.9M
Q3 25
$7.5M
$10.9M
Q2 25
$10.1M
$10.9M
Q1 25
$12.9M
$10.9M
Q4 24
$15.9M
$10.9M
Q3 24
$20.1M
$10.9M
Q2 24
$21.1M
$10.8M
Q1 24
$24.3M
$10.8M
Stockholders' Equity
BLFS
BLFS
FUSB
FUSB
Q4 25
$371.9M
$105.6M
Q3 25
$353.7M
$104.2M
Q2 25
$347.2M
$101.9M
Q1 25
$352.6M
$101.2M
Q4 24
$348.9M
$98.6M
Q3 24
$325.5M
$98.5M
Q2 24
$321.4M
$93.8M
Q1 24
$333.4M
$92.3M
Total Assets
BLFS
BLFS
FUSB
FUSB
Q4 25
$405.9M
$1.2B
Q3 25
$392.1M
$1.1B
Q2 25
$387.2M
$1.1B
Q1 25
$395.1M
$1.1B
Q4 24
$399.5M
$1.1B
Q3 24
$381.7M
$1.1B
Q2 24
$375.0M
$1.1B
Q1 24
$401.6M
$1.1B
Debt / Equity
BLFS
BLFS
FUSB
FUSB
Q4 25
0.01×
0.10×
Q3 25
0.02×
0.10×
Q2 25
0.03×
0.11×
Q1 25
0.04×
0.11×
Q4 24
0.05×
0.11×
Q3 24
0.06×
0.11×
Q2 24
0.07×
0.12×
Q1 24
0.07×
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLFS
BLFS
FUSB
FUSB
Operating Cash FlowLast quarter
$4.9M
$12.3M
Free Cash FlowOCF − Capex
$9.1M
FCF MarginFCF / Revenue
87.2%
Capex IntensityCapex / Revenue
31.1%
Cash ConversionOCF / Net Profit
0.44×
5.79×
TTM Free Cash FlowTrailing 4 quarters
$16.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLFS
BLFS
FUSB
FUSB
Q4 25
$4.9M
$12.3M
Q3 25
$6.1M
$4.2M
Q2 25
$7.4M
$3.9M
Q1 25
$1.7M
$1.8M
Q4 24
$1.6M
$7.8M
Q3 24
$4.8M
$1.9M
Q2 24
$6.5M
$2.5M
Q1 24
$-4.5M
$825.0K
Free Cash Flow
BLFS
BLFS
FUSB
FUSB
Q4 25
$9.1M
Q3 25
$3.6M
Q2 25
$1.6M
Q1 25
$1.7M
Q4 24
$5.7M
Q3 24
$1.3M
Q2 24
$2.3M
Q1 24
$-142.0K
FCF Margin
BLFS
BLFS
FUSB
FUSB
Q4 25
87.2%
Q3 25
34.2%
Q2 25
16.0%
Q1 25
17.2%
Q4 24
58.2%
Q3 24
12.7%
Q2 24
23.5%
Q1 24
-1.4%
Capex Intensity
BLFS
BLFS
FUSB
FUSB
Q4 25
31.1%
Q3 25
5.9%
Q2 25
21.8%
Q1 25
0.7%
Q4 24
21.6%
Q3 24
6.6%
Q2 24
2.0%
Q1 24
9.8%
Cash Conversion
BLFS
BLFS
FUSB
FUSB
Q4 25
0.44×
5.79×
Q3 25
9.83×
2.18×
Q2 25
25.16×
Q1 25
0.99×
Q4 24
0.13×
4.53×
Q3 24
0.87×
Q2 24
1.20×
Q1 24
0.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons